Lotte Construction Completes Framework Construction of Affiliate's Songdo Bio Campus First Plant

Antibody Pharmaceutical Production Facility
Targeting Completion in the Second Half of Next Year

Lotte Construction announced on September 10 that it has completed the structural framework for the first plant of Lotte Biologics Songdo Bio Campus, a subsidiary of the group. The company held a topping-out ceremony at the advanced industrial cluster site in Songdo International City, Incheon the previous day, wishing for the safe completion of the project.

The first plant of the Songdo Bio Campus is a state-of-the-art facility for producing antibody pharmaceuticals, with a total floor area of 99,558 square meters. It is designed to house three production lines, each with a capacity of 120,000 liters. The framework was completed in just 18 months after construction began in March 2024. The target for full completion is the second half of 2026.

Lotte Construction held a topping-out ceremony for the first plant of the Incheon Lotte Biologics Songdo Bio Campus on the 9th. The topping-out ceremony is an event where the ridge beam, the uppermost member of the roof in traditional architecture, is raised. Along with the topping-out inscription containing the date and prayers, it marks the birth of the building and wishes for safety and well-being. Provided by Lotte Construction

Lotte Construction plans to build the first plant based on the "smart factory" concept, aiming to maximize production efficiency and advance its quality management system.

A representative from Lotte Construction stated, "We hope that, following the completion of the Songdo Bio Campus plant, Lotte Biologics will grow into a top-tier global contract development and manufacturing organization."

This content was produced with the assistance of AI translation services.